David S.P. Tan

11.1k citations
197 papers · 5.4k · 2 hit papers · h-index 39

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 1%
    • PARP inhibition in cancer therapy
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis

Papers in

    • PARP inhibition in cancer therapy 32
    • Cancer Immunotherapy and Biomarkers 15
    • Ovarian cancer diagnosis and treatment 60

David S.P. Tan

176 papers receiving 5.3k citations

David S.P. Tan's Hit Papers

Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 2023 · 170 citations
1700+4+8Years since publication100200300400

Peers

David S.P. Tan
Comparison fields: 5 of 137
  • Reproductive Medicine 1.0k
  • Oncology 2.1k
  • Cancer Research 1.1k
  • Obstetrics and Gynecology 236
  • Molecular Biology 1.9k
Replace Christina M. Annunziata with:
Christina M. Annunziata United States
Stéphanie Lheureux Canada
Daniel Rosen United States
Robert M. Wenham United States
Stanley B. Kaye United Kingdom
Anne‐Marie Mes‐Masson Canada
Hal W. Hirte Canada
Kenjiro Sawada Japan
Kimberly R. Kalli United States
Paul Haluska United States
David S.P. Tan relative to Christina M. Annunziata United States Christina M. Annunziata's profile →
Citations per field
00.5×1.5×
Christina M. Annunziata · 1×
Citations per year

Countries citing papers authored by David S.P. Tan

Since Specialization
Citations

This map shows the geographic impact of David S.P. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S.P. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S.P. Tan more than expected).

Fields of papers citing papers by David S.P. Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S.P. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S.P. Tan. The network helps show where David S.P. Tan may publish in the future.

Co-authors

The 25 scholars most cited alongside David S.P. Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David S.P. Tan Line = papers co-authored together David S.P. Tan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 197 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Hit paper breakdown →
2013423
2 2006407
3 2008354
4 2007265
5 2010257
6 2018228
7
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Hit paper breakdown →
2023170
8 2009156
9 2009125
10 2008115
11 2021107
12 2020100
13 202298
14 200691
15 201191
16 202188
17 201081
18 201475
19 201875
20 201372

About David S.P. Tan

David S.P. Tan is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 197 papers that have together received 5.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (60 papers), PARP inhibition in cancer therapy (32 papers), Endometrial and Cervical Cancer Treatments (22 papers), Cancer Genomics and Diagnostics (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), DNA Repair Mechanisms (12 papers), BRCA gene mutations in cancer (10 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Reproductive Medicine (1.0k citations), Oncology (2.1k citations), Cancer Research (1.1k citations), Obstetrics and Gynecology (236 citations) and Molecular Biology (1.9k citations). David S.P. Tan has collaborated with scholars based in Singapore, United Kingdom and United States. Frequent co-authors include Stan B. Kaye, Stanley B. Kaye, Jorge S. Reis‐Filho, Emma Kipps, Roshan Agarwal, Natalie Y.L. Ngoi, Mitch Dowsett, Alan Mackay, Rachael Natrajan and Caterina Marchiò. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer, Journal of Gynecologic Oncology and The Journal of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact